Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.76 |
| ▸ | TSHR | P16473 | 2/20 | 0.76 |
| ▸ | THPO | P40225 | 2/20 | 0.76 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.76 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.76 |
| ▸ | GLA | P06280 | 1/20 | 0.76 |
| ▸ | EIF4E | P06730 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.76 |
| ▸ | TOP1 | P11387 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taribavirin SCHEMBL3868643 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL2619250 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL12758161 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL3307695 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL3307685 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL4967368 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL16330745 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL6981526 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL2631656 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR | |
| Taribavirin SCHEMBL18735565 | 1.00 | PNP (1.00) | PNPLMNASMN1; SMN2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2755 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-3790536-B1 | NANOCONTAINERS FOR TRANSPORTING NONPOLAR, LIPOPHILIC SUBSTANCES SUCH AS ANTIBIOTICS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-04-22 | — | — | EP | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4673568-A1 | MICROBIAL BIOMARKERS IN TRANSPLANTATION AND RELATED METHODS | Karius, Inc. (US) | 2026-01-07 | — | — | EP | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4566670-A2 | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS | Gilead Sciences, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| US-6680292-B1 | STIMULATION OF NEURONAL SURVIVAL, PROLIFERATION AND NEURITE ELONGATION | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2004-01-20 | — | — | US | claimed |
| CN-1447692-A | Methods of drug delivery to hepatocytes and treatment of flavivirus infections | ICN PHARMACEUTICALS (US) | 2003-10-08 | — | — | CN | claimed |
| EP-1313469-A1 | METHODS OF DRUG DELIVERY TO HEPATOCYTES AND TREATMENT OF FLAVIVIRIDAE INFECTIONS | Ribapharm, Inc. (US) | 2003-05-28 | — | — | EP | claimed |
| WO-2002015904-B1 | METHODS OF DRUG DELIVERY TO HEPATOCYTES AND TREATMENT OF FLAVIVIRIDAE INFECTIONS | ICN PHARMACEUTICALS (US) | 2002-07-04 | — | — | WO | claimed |
| WO-2002015904-A1 | METHODS OF DRUG DELIVERY TO HEPATOCYTES AND TREATMENT OF FLAVIVIRIDAE INFECTIONS | RIBAPHARM, INC. (US) | 2002-02-28 | — | — | WO | claimed |
| WO-2000030656-A9 | NEURON STIMULATION BY RIBAVIRIN, AND ANALOGS THEREOF | SALK INST FOR BIOLOGICAL STUDI (US) | 2001-12-13 | — | — | WO | claimed |
| WO-2000030656-A1 | NEURON STIMULATION BY RIBAVIRIN, AND ANALOGS THEREOF | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2000-06-02 | — | — | WO | claimed |
| EP-0374096-B1 | COMBINATION THERAPY INVOLVING 2',3'-DIDEOXYPURINE NUCLEOSIDE AND AN INHIBITOR OF PURINE NUCLEOSIDE PHOSPHORYLASE, AND ITS COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-12-02 | — | — | EP | claimed |
| EP-0374096-A1 | Combination therapy involving 2',3'-dideoxypurine nucleoside and an inhibitor of purine nucleoside phosphorylase, and its compositions | CIBA-GEIGY AG (CH) | 1990-06-20 | — | — | EP | claimed |
| US-RE29835-E | PHARMACEUTICAL | ICN PHARMACEUTICALS (US) | 1978-11-14 | — | — | US | claimed |